|
Octreotide AcetateDrug - Octreotide Acetate The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Octreotide Acetate
Strength -
EQ 0.05MG BASE/ML
Applicant -
SICOR PHARMS
New Drug Application (NDA) Number -
075957
Product Number -
001
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Oct 3, 2005
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Sicor Pharmaceuticals Inc
Octreotide Acetate
Octreotide Acetate Eq 0.05mg Base/ml Injectable; Injection
Mykacet 100,000 Units/gm;0.1% Ointment; Topical Mytrex F 100,000 Units/gm;0.1% Ointment; Topical Nystatin And Triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Nystatin And Triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Nystatin And Triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Nystatin-triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Nystatin-triamcinolone Acetonide 100,000 Units/gm;0.1% Ointment; Topical Octreotide Acetate Eq 0.2mg Base/ml Injectable; Injection Octreotide Acetate Eq 1mg Base/ml Injectable; Injection NewDrugInformation |